B-TIC

Welcome to the Brand page for “B-TIC”, which is offered here for Pharmaceuticals for the treatment of cancer and autoimmune diseases; sanitary preparations for medical purposes; dietetic foods and beverages adapted for medical use; medicines for human purposes, medicines for treating cancer and autoimmune diseases; chemical preparations for medical or pharmaceutical purposes, treating cancer and autoimmune diseases; vaccines; serums; chemical reagents for medical use; disinfectants; pharmaceutical preparations for the treatment of autoimmune diseases; immunostimulants; immunomodulators; immunoassay reagents for medical use; biological preparations for the treatment of cancer; biological preparations for the treatment of cancer and autoimmune diseases; monoclonal antibodies for use in disease testing;provision of medical services; advice relating to immunology; therapy services in the nature of therapeutic health care services;scientific and technological services, research and design in the field of medicine and health; design and development of software and data bases; medical research; research relating to biology and biotechnology; pharmaceutical research services; clinical research in the field of cancer and autoimmune diseases; research and development services in the field of immunology; research and development in the field of microorganisms, cells and antibodies; research and development of vaccines and medicines; biological analysis; biological laboratory services; advice on research and development in the field of therapeutics; laboratory services relating to the production of monoclonal antibodies; research and development services in the field of antibodies;.

Its status is currently believed to be active. Its class is unavailable. “B-TIC” is believed to be currently owned by “OSE IMMUNOTHERAPEUTICS”.